Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

MT newswireMT newswire2026/08/24 12:24
08:24 AM EDT, 08/24/2026 (MT Newswires) -- Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease. The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027. Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings. Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03

Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.

On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.

华尔街见闻•2026/11/10 23:01
Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.